Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Epiglottitis Treatment Market Size study, By Drug Type (Broad-Spectrum Antibiotics, Targeted Antibiotic, Steroid Medication), By Route of Administration (Oral Epiglottitis Treatment, Parental Epiglottitis Treatment), By End User (Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Clinics, Online Pharmacies), and Regional Forecasts 2022-2028

  • BIZ4983399
  • 200 Pages
  • July 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
Global Epiglottitis Treatment Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. The Epiglottitis is an infectious diseases caused by an infection from Haemophilus influenza type b (Hib) bacteria. In this condition epiglottis, a thin cartilage structure at the root of the tongue that closes off the windpipe when food is swallowed. Most common symptom of epiglottis are sour throat, discomfort in breathing, fever, and drooling etc. The increasing incidences of epiglottitis and growing per capita healthcare spending are factors that are accelerating the global market demand. For instance, according to National Center for Biotechnology Information estimates – the incidence rate of acute epiglottitis in adults ranges from 0.97 to 3.1 per 100,000, and a mortality rate of 7.1%. Moreover, as per Statista – in 2019, the global per capita health spending was estimated at USD 1,129, and as per estimation this amount is projected to grow to USD 1515 by 2050. Also, growing healthcare infrastructure in emerging economies coupled with increasing prevalence of bacterial diseases are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, side effects associated with Epiglottitis Treatment drugs impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Epiglottitis Treatment Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing prevalence of immune system related diseases and presence of leading pharmaceuticals companies in the region. Whereas, Asia pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as growing incidences of bacterial diseases and rising healthcare sector in the region, would create lucrative growth prospects for the global Epiglottitis Treatment Market across the Asia Pacific region.

Major market players included in this report are:

Abbott

Merck & Co., Inc.

AstraZeneca

Boehringer Ingelheim International GmbH

Pfizer Inc.

Sanofi

Teva Pharmaceutical Industries Ltd.

GlaxoSmithKline Plc.

Johnson & Johnson

Roche Holding AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Type:

Broad-Spectrum Antibiotics

Targeted Antibiotic

Steroid Medication

By Route of Administration:

Oral Epiglottitis Treatment

Parental Epiglottitis Treatment

By End User:

Hospitals Pharmacies

Retail Pharmacies

Drug Stores

Clinics

Online Pharmacies

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020

Base year – 2021

Forecast period – 2022 to 2028

Target Audience of the Global Epiglottitis Treatment Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)

1.2.1. Global Epiglottitis Treatment Market, by Region, 2020-2028 (USD Million)

1.2.2. Global Epiglottitis Treatment Market, by Drug Type, 2020-2028 (USD Million)

1.2.3. Global Epiglottitis Treatment Market, by Route of Administration, 2020-2028 (USD Million)

1.2.4. Global Epiglottitis Treatment Market, by End User, 2020-2028 (USD Million)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Epiglottitis Treatment Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Epiglottitis Treatment Market Dynamics

3.1. Epiglottitis Treatment Market Impact Analysis (2020-2028)

3.1.1. Market Drivers

3.1.1.1. Increasing incidences of epiglottitis.

3.1.1.2. Growing per capita healthcare spending.

3.1.2. Market Challenges

3.1.2.1. Side effects associated with Epiglottitis Treatment drugs.

3.1.3. Market Opportunities

3.1.3.1. Growing healthcare infrastructure in emerging economies.

3.1.3.2. Increasing prevalence of bacterial diseases.

Chapter 4. Global Epiglottitis Treatment Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

4.5. Top investment opportunity

4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry

5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Epiglottitis Treatment Market, by Drug Type

6.1. Market Snapshot

6.2. Global Epiglottitis Treatment Market by Drug Type, Performance - Potential Analysis

6.3. Global Epiglottitis Treatment Market Estimates & Forecasts by Drug Type 2018-2028 (USD Million)

6.4. Epiglottitis Treatment Market, Sub Segment Analysis

6.4.1. Broad-Spectrum Antibiotics

6.4.2. Targeted Antibiotic

6.4.3. Steroid Medication

Chapter 7. Global Epiglottitis Treatment Market, by Route of Administration

7.1. Market Snapshot

7.2. Global Epiglottitis Treatment Market by Route of Administration, Performance - Potential Analysis

7.3. Global Epiglottitis Treatment Market Estimates & Forecasts by Route of Administration 2018-2028 (USD Million)

7.4. Epiglottitis Treatment Market, Sub Segment Analysis

7.4.1. Oral Epiglottitis Treatment

7.4.2. Parental Epiglottitis Treatment

Chapter 8. Global Epiglottitis Treatment Market, by End User

8.1. Market Snapshot

8.2. Global Epiglottitis Treatment Market by End User, Performance - Potential Analysis

8.3. Global Epiglottitis Treatment Market Estimates & Forecasts by End User 2018-2028 (USD Million)

8.4. Epiglottitis Treatment Market, Sub Segment Analysis

8.4.1. Hospitals Pharmacies

8.4.2. Retail Pharmacies

8.4.3. Drug Stores

8.4.4. Clinics

8.4.5. Online Pharmacies

Chapter 9. Global Epiglottitis Treatment Market, Regional Analysis

9.1. Epiglottitis Treatment Market, Regional Market Snapshot

9.2. North America Epiglottitis Treatment Market

9.2.1. U.S. Epiglottitis Treatment Market

9.2.1.1. Drug Type estimates & forecasts, 2018-2028

9.2.1.2. Route of Administration estimates & forecasts, 2018-2028

9.2.1.3. End User estimates & forecasts, 2018-2028

9.2.2. Canada Epiglottitis Treatment Market

9.3. Europe Epiglottitis Treatment Market Snapshot

9.3.1. U.K. Epiglottitis Treatment Market

9.3.2. Germany Epiglottitis Treatment Market

9.3.3. France Epiglottitis Treatment Market

9.3.4. Spain Epiglottitis Treatment Market

9.3.5. Italy Epiglottitis Treatment Market

9.3.6. Rest of Europe Epiglottitis Treatment Market

9.4. Asia-Pacific Epiglottitis Treatment Market Snapshot

9.4.1. China Epiglottitis Treatment Market

9.4.2. India Epiglottitis Treatment Market

9.4.3. Japan Epiglottitis Treatment Market

9.4.4. Australia Epiglottitis Treatment Market

9.4.5. South Korea Epiglottitis Treatment Market

9.4.6. Rest of Asia Pacific Epiglottitis Treatment Market

9.5. Latin America Epiglottitis Treatment Market Snapshot

9.5.1. Brazil Epiglottitis Treatment Market

9.5.2. Mexico Epiglottitis Treatment Market

9.6. Rest of The World Epiglottitis Treatment Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies

10.2. Company Profiles

10.2.1. Abbott

10.2.1.1. Key Information

10.2.1.2. Overview

10.2.1.3. Financial (Subject to Data Availability)

10.2.1.4. Product Summary

10.2.1.5. Recent Developments

10.2.2. Merck & Co., Inc.

10.2.3. AstraZeneca

10.2.4. Boehringer Ingelheim International GmbH

10.2.5. Pfizer Inc.

10.2.6. Sanofi

10.2.7. Teva Pharmaceutical Industries Ltd.

10.2.8. GlaxoSmithKline Plc.

10.2.9. Johnson & Johnson

10.2.10. Roche Holding AG

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.2. Research Attributes

11.3. Research Assumption

List of Tables

TABLE 1. Global Epiglottitis Treatment Market, report scope

TABLE 2. Global Epiglottitis Treatment Market estimates & forecasts by Region 2018-2028 (USD Million)

TABLE 3. Global Epiglottitis Treatment Market estimates & forecasts by Drug Type 2018-2028 (USD Million)

TABLE 4. Global Epiglottitis Treatment Market estimates & forecasts by Route of Administration 2018-2028 (USD Million)

TABLE 5. Global Epiglottitis Treatment Market estimates & forecasts by End User 2018-2028 (USD Million)

TABLE 6. Global Epiglottitis Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 7. Global Epiglottitis Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 8. Global Epiglottitis Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 9. Global Epiglottitis Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 10. Global Epiglottitis Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 11. Global Epiglottitis Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 12. Global Epiglottitis Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 13. Global Epiglottitis Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 14. Global Epiglottitis Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 15. Global Epiglottitis Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 16. U.S. Epiglottitis Treatment Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 17. U.S. Epiglottitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 18. U.S. Epiglottitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 19. Canada Epiglottitis Treatment Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 20. Canada Epiglottitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 21. Canada Epiglottitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 22. UK Epiglottitis Treatment Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 23. UK Epiglottitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 24. UK Epiglottitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 25. Germany Epiglottitis Treatment Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 26. Germany Epiglottitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 27. Germany Epiglottitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 28. RoE Epiglottitis Treatment Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 29. RoE Epiglottitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 30. RoE Epiglottitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 31. China Epiglottitis Treatment Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 32. China Epiglottitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 33. China Epiglottitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 34. India Epiglottitis Treatment Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 35. India Epiglottitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 36. India Epiglottitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 37. Japan Epiglottitis Treatment Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 38. Japan Epiglottitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 39. Japan Epiglottitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 40. RoAPAC Epiglottitis Treatment Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 41. RoAPAC Epiglottitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 42. RoAPAC Epiglottitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 43. Brazil Epiglottitis Treatment Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 44. Brazil Epiglottitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 45. Brazil Epiglottitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 46. Mexico Epiglottitis Treatment Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 47. Mexico Epiglottitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 48. Mexico Epiglottitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 49. RoLA Epiglottitis Treatment Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 50. RoLA Epiglottitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 51. RoLA Epiglottitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 52. Row Epiglottitis Treatment Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 53. Row Epiglottitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 54. Row Epiglottitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 55. List of secondary sources, used in the study of global Epiglottitis Treatment Market

TABLE 56. List of primary sources, used in the study of global Epiglottitis Treatment Market

TABLE 57. Years considered for the study

TABLE 58. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390